Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Condensed Consolidated Statements of Operations        
Revenues $ 28,564 $ 22,660 $ 78,550 $ 60,504
Cost of goods sold 4,510 3,464 12,468 9,282
Gross profit 24,054 19,196 66,082 51,222
Costs and expenses:        
Sales and marketing 18,245 14,653 53,146 41,149
Research and development 4,181 3,307 12,602 7,967
General and administrative 7,740 6,071 24,321 16,751
Total costs and expenses 30,166 24,031 90,069 65,867
Loss from operations (6,112) (4,835) (23,987) (14,645)
Other income (expense):        
Investment income 555 727 1,925 884
Interest expense (7) 6 (32) (1,124)
Interest expense - deferred financing costs       (81)
Loss on extinguishment of debt       (2,186)
Other expense (7)   (3) (16)
Total other income (expense), net 541 733 1,890 (2,523)
Net Loss $ (5,571) $ (4,102) $ (22,097) $ (17,168)
Weighted average common shares outstanding - basic and diluted 39,340,492 38,504,810 39,151,218 36,582,261
Loss per common share - basic and diluted $ (0.14) $ (0.11) $ (0.56) $ (0.47)